Literature DB >> 3297123

A pragmatic approach to the pressor dose-response as an index of vascular reactivity and adrenoceptor function in man.

D J Sumner, H L Elliott, J Vincent, J L Reid.   

Abstract

In clinical pharmacological studies, where it is not possible to describe the full dose-response curve, the construction of dose-response relationships ideally depends upon achieving a reproducible and readily measurable response for each dose administered. This study investigates in normotensive males the technique of dose-response analysis for the blood pressure and heart rate increases with constant infusions of incremental doses of vasoactive drugs, particularly catecholamines. Steady state responses could be adequately obtained using 5 min infusion periods (at each dose level) for noradrenaline and alpha-methyl noradrenaline. At least 7 min was required for phenylephrine and 8 min for isoprenaline. There was an approximate correlation between the time to achieve the steady state response and the half-life of the offset of the agonist effect. For interindividual comparisons it is desirable to compare steady state responses and so the time at each dose level will vary according to which agonist is being used. For intraindividual comparisons it may not be essential that steady state responses are achieved. For example, assessment of the effect of prazosin on the responses to phenylephrine, by calculation of dose ratios, indicated that 5 min dose intervals were adequate.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3297123      PMCID: PMC1386185          DOI: 10.1111/j.1365-2125.1987.tb03085.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  3 in total

1.  Adrenaline and hypertension.

Authors:  M J Brown; C T Dollery
Journal:  Clin Exp Hypertens A       Date:  1984

2.  The effect of adrenaline upon cardiovascular and metabolic functions in man.

Authors:  I W Fellows; T Bennett; I A MacDonald
Journal:  Clin Sci (Lond)       Date:  1985-08       Impact factor: 6.124

3.  Analysis of the pressor dose response.

Authors:  D J Sumner; H L Elliott; J L Reid
Journal:  Clin Pharmacol Ther       Date:  1982-10       Impact factor: 6.875

  3 in total
  11 in total

1.  A clinical pharmacological assessment of doxazosin and enalapril in combination.

Authors:  A D Bainbridge; P A Meredith; H L Elliott
Journal:  Br J Clin Pharmacol       Date:  1993-12       Impact factor: 4.335

2.  A comparative assessment of the duration of action of amlodipine and nifedipine GITS in normotensive subjects.

Authors:  S Ueda; P A Meredith; C A Howie; H L Elliott
Journal:  Br J Clin Pharmacol       Date:  1993-12       Impact factor: 4.335

3.  Comparison of the antagonistic activity of tamsulosin and doxazosin at vascular alpha 1-adrenoceptors in humans.

Authors:  K Harada; M Ohmori; A Fujimura
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

4.  Pharmacological properties of nebivolol in man.

Authors:  L M Van Bortel; J N de Hoon; M J Kool; J A Wijnen; C I Vertommen; L G Van Nueten
Journal:  Eur J Clin Pharmacol       Date:  1997       Impact factor: 2.953

5.  An evaluation of the alpha-adrenoceptor antagonism produced by SK&F 86466 in healthy normotensive males.

Authors:  R F Schafers; H L Elliott; C A Howie; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1990-12       Impact factor: 4.335

Review 6.  The pressor dose-response in clinical cardiovascular pharmacology.

Authors:  D J Sumner; H L Elliott
Journal:  Br J Clin Pharmacol       Date:  1987-05       Impact factor: 4.335

7.  The dose dependency of the alpha- and beta-adrenoceptor antagonist activity of carvedilol in man.

Authors:  T C Tham; S Guy; B J McDermott; R G Shanks; J G Riddell
Journal:  Br J Clin Pharmacol       Date:  1995-07       Impact factor: 4.335

8.  Beta-adrenergic receptor responsiveness to isoprenaline in humans: concentration-effect, as compared with dose-effect evaluation and influence of autonomic reflexes.

Authors:  A Martinsson; K Lindvall; A Melcher; P Hjemdahl
Journal:  Br J Clin Pharmacol       Date:  1989-07       Impact factor: 4.335

9.  A study of the alpha-1 adrenoceptor blocker prazosin in the prophylactic management of autonomic dysreflexia in high spinal cord injury patients.

Authors:  H Krum; W J Louis; D J Brown; L G Howes
Journal:  Clin Auton Res       Date:  1992-04       Impact factor: 4.435

10.  Dose-dependent alpha 1-adrenoceptor antagonist activity of the anti-arrhythmic drug, abanoquil (UK-52,046), without reduction in blood pressure in man.

Authors:  T C Tham; S Guy; R G Shanks; D W Harron
Journal:  Br J Clin Pharmacol       Date:  1992-04       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.